British American Tobacco's shares tumble; conclusions after 2024 earnings reportšŸ’”

2:38 pm 13 February 2025

Shares of British American Tobacco (BATS.UK) are losing 7.5% in today's session, after the company's forecasts for revenue growth in fiscal 2025 did not prove good enough to sustain the sizable gains we've seen in the company's stock recently. However, this does not change the fact that the results themselves were relatively good. In F2024, the decline in operating profit in the US (-3.5%) was more than offset by growth in other countries (+7.5%), allowing BAT to maintain group-level growth (+1.4%). The performance of new non-combustion alternative product categories, such as Velo, is also encouraging.Ā 

The company sees the main negative factors for the year as:

Start investing today or test a free demo

Open real account TRY DEMO Download mobile app Download mobile app
  • Bangladesh: Acceleration of illegal trade driven by VAT and customs duty increases. (BAT's largest market)
  • Australia: Acceleration of illegal trade driven by ad hoc excise tax increases

The negative impact is estimated at: ~1% on revenues, ~2% on operating profit

Below are selected results presented by the company:

ANNUAL FORECAST

  • Adjusted operating profit +1.5% to +2.5%

The most important aspects that may affect share valuation this year. Source: BAT

2024 EARNINGS

  • Adjusted operating profit Ā£11.89 billion, estimates Ā£11.96 billion
  • Operating profit Ā£2.74 billion vs. last year's loss Ā£15.75 billion y/y, estimate Ā£10.71 billion
  • Revenue Ā£25.87 billion, estimates Ā£26.31 billion
  • Dividend per share 240.24 pence, forecast 237.55 pence
  • Adjusted earnings per share 362.5 pence, forecast 362.9 pence

CONCLUSIONS:

The company's results do not fare badly, although after such a large appreciation in BATS' share price, a large part of the market might have expected the future outlook to be more optimistic. Industry media reported that a key topic during this release would be any mention of the performance of alternative products. In this aspect, the results did not spoil, indicating a nearly 6% decline in vaporizer volumes and a nearly 12% decline in heater volumes (the company's key alternative products). Thus, they offset the positive surprise of the powerful growth in sales of Velo pouches. It is worth remembering that for tobacco companies, the key element of the transformation will be precisely the increase in the share of alternative products in the revenue structure.

Share of each group in BATS revenue. Source: BAT

The company's shares tested the 50-day EMA today (blue curve on the chart), after which the demand side managed to negate part of the initial discounts.Ā 

Source: xStation


Ā 

The content of this report has been created by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, (KRS number 0000217580) and supervised by Polish Supervision Authority ( No. DDM-M-4021-57-1/2005). This material is a marketing communication within the meaning of Art. 24 (3) of Directive 2014/65/EU of the European Parliament and of the Council of 15 May 2014 on markets in financial instruments and amending Directive 2002/92/EC and Directive 2011/61/EU (MiFID II). Marketing communication is not an investment recommendation or information recommending or suggesting an investment strategy within the meaning of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC and Commission Delegated Regulation (EU) 2016/958 of 9 March 2016 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council with regard to regulatory technical standards for the technical arrangements for objective presentation of investment recommendations or other information recommending or suggesting an investment strategy and for disclosure of particular interests or indications of conflicts of interest or any other advice, including in the area of investment advisory, within the meaning of the Trading in Financial Instruments Act of 29 July 2005 (i.e. Journal of Laws 2019, item 875, as amended). The marketing communication is prepared with the highest diligence, objectivity, presents the facts known to the author on the date of preparation and is devoid of any evaluation elements. The marketing communication is prepared without considering the clientā€™s needs, his individual financial situation and does not present any investment strategy in any way. The marketing communication does not constitute an offer of sale, offering, subscription, invitation to purchase, advertisement or promotion of any financial instruments. XTB S.A. is not liable for any clientā€™s actions or omissions, in particular for the acquisition or disposal of financial instruments, undertaken on the basis of the information contained in this marketing communication. In the event that the marketing communication contains any information about any results regarding the financial instruments indicated therein, these do not constitute any guarantee or forecast regarding the future results.

Share:
Back

Join over 1 000 000 XTB Group Clients from around the world.